A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)

This trial is testing a new drug called AUR104 in people with blood cancers — including chronic lymphocytic leukemia (CLL) and various lymphomas — that have come back after treatment or stopped responding. **You may be eligible if...** - You are 18 or older - You have a relapsed or treatment-resistant lymphoid cancer (such as CLL, follicular lymphoma, diffuse large B-cell lymphoma, or related blood cancers) - You are in reasonably good health (ECOG 0–1) - Your blood counts and organ function meet required levels **You may NOT be eligible if...** - Your blood counts are too low (severe anemia, low platelets, or low white blood cells) - Your liver function is significantly impaired - You have active uncontrolled infections - You have conditions that would make the study unsafe for you Talk to your doctor to see if this trial is right for you.